NWF Advisory Services’s Cytosorbents Corp CTSO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-5,207
Closed -$38.9K – 449
2026
Q2
$38.9K Hold
5,207
– – ﹤0.01% 449
2026
Q1
$59K Hold
5,207
– – 0.01% 400
2025
Q4
$66.6K Hold
5,207
– – 0.01% 398
2025
Q3
$97.3K Hold
5,207
– – 0.01% 399
2025
Q2
$133K Hold
5,207
– – 0.02% 391
2025
Q1
$104K Buy
+5,207
New +$110K 0.01% 347
2024
Q4
– Sell
-3,340
Closed -$100K – 311
2024
Q3
$100K Buy
3,340
+500
+18% +$11K 0.01% 328
2024
Q2
$39.9K Hold
2,840
– – 0.01% 312
2024
Q1
$54K Buy
2,840
+105
+4% +$2.04K 0.01% 320
2023
Q4
$60.7K Buy
2,735
+312
+13% +$9.27K 0.01% 287
2023
Q3
$91.1K Buy
2,423
+200
+9% +$11.5K 0.02% 274
2023
Q2
$160K Hold
2,223
– – 0.04% 248
2023
Q1
$160K Buy
+2,223
New +$133K 0.04% 247

NWF Advisory Services's CTSO Position: Q3 2026 in Review

NWF Advisory Services sold out of Cytosorbents Corp (CTSO) in Q3 2026, closing a stake of 5,207 shares — an estimated $38.9K sold.

NWF Advisory Services first reported a position in CTSO in Q1 2023 and held it in 13 quarters. The position peaked at $160K in Q2 2023. 0 funds tracked by Wall St. Rank hold CTSO as of Q3 2026.

  • NWF Advisory Services reported no remaining Cytosorbents Corp position as of Q3 2026 after selling out during the quarter.
  • NWF Advisory Services sold 5,207 Cytosorbents Corp shares in Q3 2026, an estimated $38.9K.
  • NWF Advisory Services first reported a position in Cytosorbents Corp in Q1 2023 and held it in 13 quarters.
  • NWF Advisory Services's Cytosorbents Corp position peaked at $160K in Q2 2023.
  • 0 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q3 2026.

Based on NWF Advisory Services's 13F filing for Q3 2026, filed 19 Oct 2026.